LING MA, MD

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg

Administration of chemotherapy into vein, 1 hour or less

Administration of chemotherapy into vein using push technique

Injection, zoledronic acid, 1 mg

Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

New patient office or other outpatient visit, 45-59 minutes

Administration of additional new drug or substance into vein, 1 hour or less

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Injection, carboplatin, 50 mg

Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes

Administration of additional new drug or substance into vein using push technique

Infusion into a vein for hydration, 31-60 minutes

Established patient office or other outpatient visit, 30-39 minutes

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

Administration of chemotherapy into vein, each additional hour

Immunologic analysis technique on serum (immunofixation)

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Established patient office or other outpatient visit, 20-29 minutes

Injection, pembrolizumab, 1 mg

Reticulated (young) platelet measurement

Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3

Injection, palonosetron hcl, 25 mcg

Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes

Irrigation of implanted venous access drug delivery device

Injection of additional new drug or substance into vein

Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

Carcinoembryonic antigen (cea) protein level

Protein measurement, serum

Beta-2 microglobulin (protein) level

Injection of drug or substance under skin or into muscle

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Blood test, thyroid stimulating hormone (tsh)

Infusion into a vein for hydration, each additional hour

Folic acid level, serum

Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services

Injection, denosumab, 1 mg

Thyroxine (thyroid chemical), free

Blood test, comprehensive group of blood chemicals

Measurement of immunoglobulin light chains

Ferritin (blood protein) level

Gammaglobulin (immune system protein) measurement

Blood test, basic group of blood chemicals (calcium, total)

Total protein level, blood

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Iron binding capacity

Complete blood cell count (red cells, white blood cell, platelets), automated test

Lactate dehydrogenase (enzyme) level

Magnesium level